Derma Sciences (DSCI) Posts Q3 Loss of 24c/Share

Derma Sciences (NASDAQ: DSCI) reported Q3 EPS of ($0.24), $0.13 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $19.6 million versus the consensus estimate of $19 million.

For earnings history and earnings-related data on Derma Sciences (DSCI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• BIG3 Basketball to go public via Graf Global merger at $290 million
• Sharon AI surges premarket; New Oriental gains, Medline slips